SCHEMBL20737250

SCHEMBL20737250

N#Cc1ccc(N(c2ccccc2)c2ccc3c4c(c5ccccc5c3c2)-c2c(ccc3ccccc23)C42c3ccccc3-c3ccccc32)cc1

nearest known ligand 0.33

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
▸ SLC6A4 P31645 1/20 0.33
▸ CA1 P00915 1/20 0.32
▸ CA2 P00918 1/20 0.32
▸ SLC22A12 Q96S37 1/20 0.32
▸ SOS1 Q07889 1/20 0.31
▸ STK10 O94804 1/20 0.31
▸ SLK Q9H2G2 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20736254 0.92 SOS1 (0.35) SOS1
SCHEMBL27250820 0.92 SOS1 (0.35) SOS1
SCHEMBL20737810 0.89 CA1 (0.32) SLC6A4CA1CA2SOS1STK10
SCHEMBL20736018 0.88 SOS1 (0.33) SOS1
SCHEMBL20736627 0.87 PDK2 (0.32) —
SCHEMBL20735613 0.87 — —
SCHEMBL20736017 0.87 SOS1 (0.32) SOS1
SCHEMBL20736013 0.87 SOS1 (0.32) SOS1
SCHEMBL27250824 0.87 SOS1 (0.32) SOS1
SCHEMBL27250822 0.86 SIGMAR1 (0.32) SOS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12022728-B2 Organic electroluminescent element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2024-06-25 — — US disclosed
US-11552251-B2 Organic electroluminescent element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2023-01-10 — — US disclosed
US-20190051835-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2019-02-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11552251-B2 Organic electroluminescent element and electronic device L1CAM, ESR1, LEF1 SLC6A4 4207/4885CA1 2450/4885CA2 2379/4885
US-20190051835-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE L1CAM, ESR1, LEF1 SLC6A4 4207/4885CA1 2450/4885CA2 2379/4885
US-12022728-B2 Organic electroluminescent element and electronic device L1CAM, ESR1, LEF1 SLC6A4 4207/4885CA1 2450/4885CA2 2379/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback